Deals of the day-Mergers and acquisitions

Ventyx Biosciences

08/01/2026 10:34

Jan 8 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Thursday:

** Saudi Arabia's SABIC <2010.SE> has agreed to sell its European petrochemical business and its Engineering Thermoplastics business in Europe and the Americas for a combined enterprise value of $950 million, as part of a restructuring during an industry slowdown.nL6N3Y90DR

** Eli Lilly  will buy autoimmune drug developer Ventyx Biosciences  for $1.2 billion in cash, the companies said on Wednesday, marking the Zepbound maker's latest push to expand beyond its blockbuster diabetes and weight-loss drugs.nL4N3Y81JD

** AbbVie  on Wednesday denied it was in talks to buy Revolution Medicines  after the Wall Street Journal reported the drugmaker was in advanced discussions to acquire the cancer-drug developer.nL4N3Y81GA

 (Compiled by Sahil Pandey and Rajarshi Roy in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))